BMY
HealthcareBristol-Myers Squibb Company
$56.59-0.36 (-0.63%)PRE
Live · NYSE · May 9, Close
AI Insight
What's Moving BMY Today?
No stock-specific AI insight has been generated for BMY yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$41.46$62.25
$56.59
Fundamentals
Market Cap$114.9B
P/E Ratio15.8
EPS$3.57
Dividend Yield0.04%
Dividend / Share$2.50
ROE0.4%
Profit Margin0.2%
Debt / Equity—
Trading
Volume10.4M
Avg Volume (10D)—
Shares Outstanding2.04B
BMY News
48 articles- Crossmark Global Holdings Inc. Increases Stock Holdings in Bristol Myers Squibb Company $BMYMarketBeat·May 9, 2026
- Xenon Pharmaceuticals Q1 Earnings Call HighlightsMarketbeat·May 9, 2026
- Foundation Medicine Expands Bristol Myers Squibb Deal to Develop MTAP Biomarker TestClinical Lab Products·May 9, 2026
- Bristol-Myers Squibb Shareholders Approve Board and CompensationTipRanks·May 8, 2026
- BMS Gets EU Approval for Sotyktu for Treatment of Active Psoriatic ArthritisContract Pharma·May 8, 2026
- Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Pharma Sector Sentiment Shift AccuratelySimply Wall Street·May 8, 2026
- Karat Packaging Inc. (NASDAQ:KRT) Receives Consensus Recommendation of "Hold" from AnalystsMarketBeat·May 8, 2026
- Prothena Posts Q1 Earnings as Revenues Surge on Milestone PaymentYahoo Finance·May 8, 2026
- A $1.5 Million Portfolio That Quietly Pays You $83,400 a Year, No Job Required247 Wall St·May 8, 2026
- Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in AdultsYahoo Finance·May 8, 2026
- Bristol Myers Squibb Company $BMY Shares Bought by Generali Asset Management SPA SGRMarketBeat·May 8, 2026
- GRIMES & Co WEALTH MANAGEMENT LLC Reduces Position in Bristol Myers Squibb Company $BMYMarketBeat·May 8, 2026
- Milestone payment and strong cash fuel Janux (NASDAQ: JANX) pipelineStock Titan·May 8, 2026
- The Agencies Building Pharma's Next Decade Just Picked Their Software: Daily Command Launches With 18 of the Industry's Most Senior Agency Leaders Already Inside ItYahoo Finance·May 7, 2026
- Vanguard High Dividend Yield ETF Delivers 67% Five-Year Returns Against Schwab U.S. Dividend Equity ETF’s Steadier 229% Decade Gain247 Wall St·May 7, 2026
- 75 of Pharma's Most Senior Marketers Just Walked Away From a $12 Billion Tool StackYahoo Finance·May 7, 2026
- STERIS appoints Pierre Boulud to board of directors By Investing.comInvesting.com Canada·May 7, 2026
- Janux Therapeutics Reports First Quarter 2026 Financial Results and Business HighlightsYahoo Finance·May 7, 2026
- RVMD Reports Wider-Than-Expected Loss in Q1, Raises '26 Expense ViewYahoo Finance·May 7, 2026
- Thermo Fisher Scientific to sell its microbiology portfolio for $1.1bnCleanroom Technology·May 7, 2026
- Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-TermYahoo Finance·May 7, 2026
- Premier Fund Managers Ltd Invests $11.63 Million in Bristol Myers Squibb Company $BMYMarketBeat·May 7, 2026
- IgG4-Related Disease Market Analysis and Forecasts, 2025-2026 & 2035 with Amgen, Zenas BioPharma, Bristol Myers Squibb, and Sanofi LeadingYahoo Finance·May 7, 2026
- Bristol-Myers Squibb’s Q1 Earnings Call: Our Top 5 Analyst QuestionsThe Chronicle-Journal·May 7, 2026
- Oncolytics Biotech Reports Data in Colorectal Cancer StudyYahoo Finance·May 6, 2026
- Bristol Myers Squibb World Cup Push Meets Valuation And Earnings QuestionsYahoo Finance·May 6, 2026
- CYTK Q1 Earnings Match Estimates, Revenues Beat on Myqorzo LaunchYahoo Finance·May 6, 2026
- 6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash247 Wall St·May 6, 2026
- Is Bristol Myers Squibb (BMY) Offering Value After A 25.7% One Year Share Price GainYahoo Finance·May 6, 2026
- BioNTech Expands Oncology Trials And Reshapes Manufacturing As Investors Weigh UpsideYahoo Finance·May 6, 2026
- Medable CEO Michelle Longmire Featured as Guest Speaker with Leaders from Google and Mayo Clinic at Japan’s Largest Pharmaceutical SummitYahoo Finance·May 6, 2026
- Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026Yahoo Finance·May 6, 2026
- CellCentric raises $220M for a ‘transformative’ multiple myeloma medicineBiopharmadive·May 6, 2026
- Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics LandscapeGlobeNewswire Inc.·Apr 28, 2026
- Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash DealThe Motley Fool·Apr 27, 2026
- AI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive InnovationGlobeNewswire Inc.·Apr 27, 2026
- Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsightGlobeNewswire Inc.·Apr 27, 2026
- Vulvar Cancer Market Global and Regional Analysis Report 2025-2035, Profiles of Merck & Co., Bristol Myers Squibb, and AstraZenecaGlobeNewswire Inc.·Apr 22, 2026
- Follicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsightGlobeNewswire Inc.·Apr 21, 2026
- Alpha Thalassemia (US, EU4, UK, and Japan) Market Insights, Epidemiology, and Forecasts 2022-2025 & 2025-2036GlobeNewswire Inc.·Apr 13, 2026
Price Data
Open$57.23
Previous Close$56.95
Day High$57.40
Day Low$56.36
52 Week High$62.25
52 Week Low$41.46
52-Week Range
$41.46$62.25
$56.59
Fundamentals
Market Cap$114.9B
P/E Ratio15.8
EPS$3.57
Dividend Yield0.04%
Dividend / Share$2.50
ROE0.4%
Profit Margin0.2%
Debt / Equity—
Trading
Volume10.4M
Avg Volume (10D)—
Shares Outstanding2.04B
About Bristol-Myers Squibb Company
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
HealthcareDrug Manufacturers - General
Company Details
Security TypeStock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICDrug Manufacturers - General
CIK—
Composite FIGI—
Share Class FIGI—